GlaxoSmithKline Pharmaceuticals completes VRS in field sales and HO

GlaxoSmithKline Pharmaceuticals Limited has established an Omnichannel Team to expand its reach and coverage to the target segments by leveraging technology and improve productivity.

Continuing our focus on improving operating efficiencies, the Company has also completed the Voluntary Retirement Scheme (VRS) (for Commercial function employees in Field Sales and HO) and spent a sum of Rs. 156.57 crores as the one-off cost of the VRS.

Dr. Reddy's Laboratories gets 3 observations from USFDA for R&D Centre

The United States Food & Drug Administration (USFDA) completed a GMP and Pre-Approval Inspection (PAI) at our R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad. The inspection was conducted from December 4, 2023 to December 8, 2023. The company has been issued a Form 483 with three observations, which we will address within the stipulated timeline.